Hi wizza
What I'm struggling with , if we've got the most amazing valve out there and a heap of surgeons are raving about it, then why are we thinking about only taking half the market.
You'd have to be crazy not to take DurVAR.
And , when you look at the fact it can be used in a lot younger patients than previous valves, you have gained an extra number of people????
Heart operations don't only happen in old folks.
Is going to be interesting.
$66.32 price target - Evolution Capital initiation of coverage, page-69
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
-0.550(3.10%) |
Mkt cap ! $330.6M | |||
| Open | High | Low | Value | Volume |
| $17.75 | $17.75 | $16.88 | $199.1K | 11.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |